drugset / Trial / NCT01211730

Study of Glycemic Control on Liver Transplantation Outcomes

NCT01211730

Phase 4 Completed 164 enrolled Northwestern University
RandomizedParallel-groupOpen-labelTreatment

Summary

Many but not all studies have shown improvement in morbidity and mortality with intensive glycemic management postoperatively. In this study, the investigators propose to determine whether improved glycemic control using intensive insulin treatment immediately postoperatively will improve outcomes in patients undergoing liver transplant using a prospective, controlled, randomized, parallel-group study design targeting two different glucose levels, 140 and 180 mg/dL.

Timeline

Start
2009-04
Primary completion
2015-12
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin aspart Protein / enzyme biologic Subcutaneous
Comparator insulin glargine Protein / enzyme biologic Subcutaneous

Indications